FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

3587611000001102: Carbidopa monohydrate (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2017. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    14887301000001112 Carbidopa monohydrate (substance) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    14887401000001116 Carbidopa monohydrate en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Carbidopa monohydrate Is a Carbidopa false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Co-careldopa 10mg/100mg tablets (Doncaster Pharmaceuticals Ltd) 100 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg tablets (Doncaster Pharmaceuticals Ltd) 100 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (AM Distributions (Yorkshire) Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (AM Distributions (Yorkshire) Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (J M McGill Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (J M McGill Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (Niche Pharma Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Niche Pharma Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (Niche Pharma Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Niche Pharma Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (DE Pharmaceuticals) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (DE Pharmaceuticals) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (CST Pharma Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (CST Pharma Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (DE Pharmaceuticals) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (DE Pharmaceuticals) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (CST Pharma Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (CST Pharma Ltd) 50 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (CST Pharma Ltd) 100 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (CST Pharma Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Colorama Pharmaceuticals Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (Icarus Pharmaceuticals Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Icarus Pharmaceuticals Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Colorama Pharmaceuticals Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (Icarus Pharmaceuticals Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Icarus Pharmaceuticals Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Apodespan PR 50mg/200mg tablets (Accord Healthcare Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Apodespan PR 50mg/200mg tablets (Accord Healthcare Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (Ennogen Healthcare Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (Ennogen Healthcare Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 12.5mg/50mg/5ml oral suspension 100 ml Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 12.5mg/50mg/5ml oral suspension (Drug Tariff Special Order) 100 ml Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (Colorama Pharmaceuticals Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (Pharma-z Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Pharma-z Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (Colorama Pharmaceuticals Ltd) 100 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (Colorama Pharmaceuticals Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (Pharma-z Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Pharma-z Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg modified-release tablets (Ennogen Healthcare Ltd) 50 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Ennogen Healthcare Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Ennogen Healthcare Ltd) 60 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg tablets (Mawdsley-Brooks & Company Ltd) 100 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Sinemet 25mg/250mg tablets (Waymade Healthcare Plc) 100 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 3.125mg/12.5mg/5ml oral suspension Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 5mg/50mg/5ml oral suspension Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 3.125mg/12.5mg/5ml oral suspension (Special Order) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 5mg/50mg/5ml oral suspension (Special Order) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 5mg/50mg/5ml oral suspension 1 ml Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 3.125mg/12.5mg/5ml oral suspension 1 ml Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 3.125mg/12.5mg/5ml oral suspension (Special Order) 1 ml Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 5mg/50mg/5ml oral suspension (Special Order) 1 ml Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg tablets (Zentiva Pharma UK Ltd) 100 tablet 10 x 10 tablets Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 12.5mg/50mg tablets (A A H Pharmaceuticals Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 12.5mg/50mg tablets (Alliance Healthcare (Distribution) Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 12.5mg/50mg tablets (A A H Pharmaceuticals Ltd) 90 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 12.5mg/50mg tablets (Alliance Healthcare (Distribution) Ltd) 90 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 10mg/100mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 10mg/100mg tablets (Zentiva Pharma UK Ltd) 100 tablet 10 x 10 tablets Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets (Zentiva Pharma UK Ltd) 100 tablet 10 x 10 tablets Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 12.5mg/50mg tablets (Somex Pharma) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 10mg/100mg tablets (Somex Pharma) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg tablets (Somex Pharma) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets (Somex Pharma) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 12.5mg/50mg tablets (Somex Pharma) 90 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 10mg/100mg tablets (Somex Pharma) 100 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/100mg tablets (Somex Pharma) 100 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets (Somex Pharma) 100 tablet Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 12.5mg/50mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 12.5mg/50mg tablets (Zentiva Pharma UK Ltd) 90 tablet 9 x 10 tablets Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 10mg/40mg/5ml oral suspension Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 10mg/40mg/5ml oral suspension (Special Order) Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 10mg/40mg/5ml oral suspension 1 ml Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier
    Co-careldopa 10mg/40mg/5ml oral suspension (Special Order) 1 ml Has specific active ingredient False Carbidopa monohydrate Inferred relationship Existential restriction modifier

    Start Previous Page 4 of 4


    This concept is not in any reference sets

    Back to Start